Joshua Blacher

Joshua Blacher is currently the Chief Financial Officer at Predictive Oncology, Inc. since 2023.
He is also working as a Consultant at Danforth Advisors LLC since 2022.
In 2019, he became the Managing Partner at Columbus Circle Capital, LLC.
Additionally, he holds the position of Chief Financial Officer at Rna Disease Diagnostics, Inc. since 2021.
In his former roles, Mr. Blacher worked as a Principal at Morgan Stanley.
From 2011 to 2014, he served as the Executive Vice President-Corporate Development at WFW Cardiac, Inc. He also held the position of Principal at the Federal Reserve Bank of New York.
Mr. Blacher was the Chief Financial Officer & Executive Vice President at Vestopia, Inc. He served as the Chief Financial Officer at SciSparc Ltd.
from 2017 to 2018.
In 2022, he briefly worked as the Chief Financial & Accounting Officer at LogicBio Therapeutics, Inc. From 2018 to 2019, he held the role of Chief Business Officer at InMed Pharmaceuticals, Inc. Mr. Blacher was also the Chief Financial Officer at SciSparc Ltd.
from 2017 to 2018.
Lastly, from 2014 to 2017, he served as the Chief Financial Officer at Galmed Pharmaceuticals Ltd.Mr. Blacher completed his undergraduate studies at Yeshiva University.
He furthered his education by obtaining an MBA from Columbia Business School.